drugset / Trial / NCT02962830
Sufentanil Pharmacokinetics After Intra Amniotic Injection
NaSingle-groupOpen-labelTreatment
Summary
The fetus may be exposed during pregnancy to nociceptive stimuli because of fetal pathology (e.g., malformation) or a diagnostic or therapeutic procedure. To date, there is very little data and no consensus on fetal analgesia. The aim of the investigators study is to evaluate the pharmacokinetics of Sufentanil after intra amniotic injection.
Timeline
- Start
- 2017-04-19
- Primary completion
- 2024-05-28
- Completion
- 2024-05-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sufentanil | Other / unclassified | 10 ug | Other |
Indications
No indication recorded.